Document:

Exhibit 10.6

 

REGISTRATION
RIGHTS AGREEMENT

 

THIS
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 30, 2022 by and among RUBICON TECHNOLOGIES,
INC. (formerly Founder SPAC) a Delaware corporation (the “Company”), and YA II PN, LTD., a Cayman
Islands exempt limited partnership (the “Investor”).

 

WITNESSETH

 

WHEREAS,
in connection with the Securities Purchase Agreement by and among the parties hereto of even date herewith (the “Securities
Purchase Agreement”), the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement,
to issue and sell to the Investor (i) up to $17,000,000 in principal amount of convertible debentures (the “Convertible Debentures”),
which shall be convertible into the Company’s Class A common stock, par value $0.0001 (the “Common Stock”) (as
converted, the “Conversion Shares”) and (ii) for a purchase price of $6,000,000, pre-paid warrants (the “Pre-Paid
Warrants”) which shall be exercisable into additional shares of Common Stock as set forth therein (the “Warrant Shares”).
Capitalized terms not defined herein shall have the meaning ascribed to them in the Securities Purchase Agreement.

 

WHEREAS,
to induce the Investor to execute and deliver the Securities Purchase Agreement, the Company has agreed to provide certain registration
rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively,
the “Securities Act”), and applicable state securities laws and other rights as provided for herein.

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the premises and the mutual covenants contained herein and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:

 

1. DEFINITIONS.

 

As
used in this Agreement, the following terms shall have the following meanings:

 

(a) “Effectiveness
Deadline” means, with respect to the Registration Statement filed hereunder in respect of the Initial Required Registration
Amount, the 60th calendar day following the date of the filing of the Registration Statement, provided, however, in the event the Company
is notified by the U.S. Securities and Exchange Commission (“SEC”) that one of the Registration Statements, as defined
below, will not be reviewed or is no longer subject to further review and comments, the Effectiveness Deadline as to such Registration
Statement shall be the fifth business day following the date on which the Company is so notified if such date precedes the date required
above.

 

(b) “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

    1

    

    

 

(c) “Filing
Deadline” means, with respect to the Registration Statement required hereunder in respect of the Initial Required Registration
Amount, the 15th calendar day following the date hereof.

 

(d) “Initial
Required Registration Amount” means with respect to the initial Registration Statement at least 19,800,000 shares of Common
Stock, consisting of Conversion Shares, subject to any reduction in the event of Cut-Back Securities.

 

(e) “Person”
means a corporation, a limited liability company, an association, a partnership, an organization, a business, an individual, a governmental
or political subdivision thereof or a governmental agency.

 

(f) “Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under
the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion
of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including
post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

 

(g) “Registrable
Securities” means all of (i) the shares of Common Stock issuable upon conversion of the Convertible Debentures, (ii) any additional
shares issuable in connection with any anti-dilution provisions of the Convertible Debentures (without giving effect to any limitations
on exercise set forth in the Convertible Debentures, as applicable) and (iii) any shares of Common Stock issued or issuable with respect
to any shares described in subsections (i) and (ii) above by way of any stock split, stock dividend or other distribution, recapitalization
or similar event or otherwise (in each case without giving effect to any limitations on exercise set forth in the Convertible Debentures).

 

(h) “Registration
Statement” means any registration statement of the Company filed pursuant to this Agreement, including the Prospectus, amendments
and supplements to such registration statement or Prospectus, including post-effective amendments, all exhibits thereto, and all material
incorporated by reference or deemed to be incorporated by reference in such registration statement.

 

(i) “Required
Registration Amount” means (i) with respect to the initial Registration Statement the Initial Required Registration Amount,
and (ii) with respect to subsequent Registration Statements such number of shares of Common Stock as requested by the Investor not to
exceed the maximum number of shares of Common Stock issuable upon conversion of all Convertible Debentures then outstanding (assuming
for purposes hereof that (x) such Convertible Debentures are convertible at the Conversion Price (as defined therein) in effect as of
the date of determination, and (y) any such conversion shall not take into account any limitations on the conversion of the Convertible
Debentures set forth therein), in each case subject to any cutback set forth in Section 2(d).

 

(j) “Rule
144” means Rule 144 under the Securities Act or any successor rule thereto.

 

    2

    

    

 

(k) “Rule
415” means Rule 415 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.

 

(l) “SEC”
means the Securities and Exchange Commission or any other federal agency administering the Securities Act and the Exchange Act at the
time.

 

(m) “Securities
Act” shall have the meaning set forth in the Recitals above.

 

2. REGISTRATION.

 

(a) The
Company’s registration obligations set forth in this Section 2 including its obligations to file Registration Statements, obtain
effectiveness of Registration Statements, and maintain the continuous effectiveness of any Registration Statement that has been declared
effective shall begin on the date hereof and continue until all the Registrable Securities and Warrant Shares have been sold or may permanently
be sold without any restrictions pursuant to Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter
to such effect (based upon such representations of the Company and the Investor as such counsel may reasonably request), addressed and
reasonably acceptable to the Company’s transfer agent (the “Registration Period”).

 

(b) Subject
to the terms and conditions of this Agreement, the Company shall (i) on or prior to the Filing Deadline, prepare and file with the SEC
an initial Registration Statement on Form S-3 (or, if the Company is not then eligible, on Form S-1) or any successor form thereto covering
the resale by the Investor of Registrable Securities, and (ii) on or prior to the 30th calendar day following receipt of each written
notice by the Investor (a “Demand Notice”) delivered pursuant to the terms hereof, prepare and file an additional
Registration Statement covering the resale by the Investor of Registrable Securities not covered by the initial Registration Statement,
or Warrant Shares, if applicable. Each Registration Statement prepared pursuant hereto shall register for resale at least the number
of shares of Common Stock equal to the Required Registration Amount as of date the Registration Statement is initially filed with the
SEC. Each Registration Statement shall contain the “Selling Stockholders” and “Plan of Distribution”
sections. The Company shall use its commercially reasonable best efforts to have each Registration Statement declared effective by the
SEC as soon as practicable, but in no event later than the Effectiveness Deadline. By 9:30 am on the business day following the date
of effectiveness, the Company shall file with the SEC in accordance with Rule 424 under the 1933 Act the final Prospectus to be used
in connection with sales pursuant to such Registration Statement.

 

For
the purposes hereof, the Investor shall be entitled to deliver a Demand Notice to the Company at any time during the Registration Period
if at such time (i) no Registration Statement is then in effect which the Investor may use to resell Registrable Securities, (ii) after
the issuance of the Convertible Debenture issued at the Second Closing (as defined in the Securities Purchase Agreement), no Registration
Statement is then in effect which the Investor may use to resell the shares of Common Stock issuable upon conversion of the Convertible
Debenture issued at the Second Closing, (iii) a Registration Statement is effective, but the Holder has resold substantially all of the
shares of Common Stock registered on such Registration Statement, or (iv) in respect of Warrant Shares, any time after the Market Price
Set Date (as defined in the Pre-Paid Warrant). In addition, the Investor may deliver a Demand Notice to the Company at any time during
the Registration Period during which (i) the Company does not have a class of securities listed, or approved for listing, on a national
securities exchange registered pursuant to Section 6 of the Exchange Act, or (ii) Rule 144, as amended, would not allow the “tacking”
of the holding period of the Convertible Debenture onto the holding period of the Conversion Shares issuable upon conversion thereof.

 

    3

    

    

 

(c) During
the Registration Period, the Company shall (i) promptly prepare and file with the SEC such amendments (including post-effective
amendments) and supplements to a Registration Statement and the Prospectus used in connection with a Registration Statement, which Prospectus
is to be filed pursuant to Rule 424 promulgated under the Securities Act, as may be necessary to keep such Registration Statement effective
at all times during the Registration Period, (ii) prepare and file with the SEC additional Registration Statements in order to register
for resale under the Securities Act all of the Registrable Securities; (iii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and as so supplemented or amended to be filed pursuant
to Rule 424; (iv) respond as promptly as reasonably possible to any comments received from the SEC with respect to a Registration Statement
or any amendment thereto and as promptly as reasonably possible provide the Investor true and complete copies of all correspondence from
and to the SEC relating to a Registration Statement (provided that the Company may excise any information contained therein which would
constitute material non-public information as to any Investor which has not executed a confidentiality agreement with the Company); and
(v) comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company covered
by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the
intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement. In the case of amendments
and supplements to a Registration Statement which are required to be filed pursuant to this Agreement (including pursuant to this Section
2(c)) by reason of the Company’s filing a report on Form 10-K, Form 10-Q, or Form 8-K or any analogous report under the Securities
Exchange Act, the Company shall incorporate such report by reference into the Registration Statement, if applicable, or shall file such
amendments or supplements with the SEC on the same day on which the Exchange Act report is filed which created the requirement for the
Company to amend or supplement the Registration Statement.

 

(d) Reduction
of Registrable Securities Included in a Registration Statement. Notwithstanding anything contained herein, in the event that the
SEC requires the Company to reduce the number of Registrable Securities to be included in a Registration Statement in order to allow
the Company to rely on Rule 415 with respect to a Registration Statement, then the Company shall be obligated to include in such Registration
Statement (which may be a subsequent Registration Statement if the Company needs to withdraw a Registration Statement and refile a new
Registration Statement in order to rely on Rule 415) only such limited portion of the Registrable Securities as the SEC shall permit,
provided however, that the Company shall use reasonable best efforts to seek the approval of the maximum number of Registrable Securities
permitted by the SEC and under applicable law. Any Registrable Securities that are excluded in accordance with the foregoing terms are
hereinafter referred to as “Cut Back Securities.” To the extent Cut Back Securities exist, promptly following such
time as may be permitted by the SEC, the Company shall be required to file a Registration Statement covering the resale of the Cut Back
Securities (subject also to the terms of this Section) and shall use commercially reasonable efforts to cause such Registration Statement
to be declared effective as promptly as practicable thereafter. If the inclusion on a registration statement of any of the (i) Registrable
Securities, (ii) Warrant Shares, (iii) shares issuable under the Equity Purchase Agreement, or (iv) shares issued or issuable pursuant
to any other security (whether debt or equity) is impermissible for any reason whatsoever (whether by law, or any interpretation or comment
issued by the SEC) or the Company determines that it is required or desirable to reduce or eliminate any shares specified in subparts
(i), (ii), (iii) or (iv) of this sentence from a registration statement, then the Company shall withdraw or reduce (as appliable), and
shall not seek to register on a registration statement, such shares in the following priority: first, subpart (iv), second, subpart (iii),
third, subpart (ii) and last, subpart (i) of this sentence. The Company here represents, warrants and covenants to Investor that this
Section 2(d) does, and will, not violate any provision of any existing or future agreement that the Company is party.

 

    4

    

    

 

(e) Failure
to File or Obtain Effectiveness of the Registration Statement or Remain Current.

 

(i) If
a Registration Statement covering the Initial Required Registration Amount is not declared effective by the SEC prior to the Effectiveness
Deadline (an “Effectiveness Failure”), then the Company will make pro rata payments to each Investor then holding
Convertible Debentures, as liquidated damages and not as a penalty (the “Liquidated Damages”), in an amount equal
to 2.0% of the aggregate principal amount of Convertible Debentures then held by such holder (x) on the initial day of a Effectiveness
Failure and (y) for each 30-day period (pro rata for any portion thereof) thereafter until the Effectiveness Failure is cured
(each, a “Blackout Period”). The Liquidated Damages shall be paid monthly within ten (10) Business Days after
the date of such Effectiveness Failure and the end of each subsequent 30-day period (or portion thereof), as applicable. Such
payments shall be made to each Investor then holding Convertible Debentures in cash.

 

(ii) The
parties agree that (1) notwithstanding anything to the contrary herein or in the Securities Purchase Agreement, no Liquidated Damages
shall be payable with respect to any period after the expiration of the Registration Period (it being understood that this sentence shall
not relieve the Company of any Liquidated Damages accruing prior to the expiration of the Registration Period), and in no event shall
the aggregate amount of Liquidated Damages payable to an Investor exceed, in the aggregate, 12.0% of the aggregate purchase price paid
by such Investor for the Convertible Debentures pursuant to the Securities Purchase Agreement.

 

(iii) If:
(i) after a Registration Statement has been declared effective by the SEC, sales cannot be made pursuant to such Registration Statement
for any reason (including, without limitation, by reason of a stop order or the Company’s failure to update such Registration Statement
but excluding any Allowable Delay or the inability of any Investor to sell the Registrable Securities covered thereby due to market conditions),
or (iii) after the date that is six months from the date hereof, the Company does not have available adequate current public information
as set forth in Rule 144(c) (any such failure or breach being referred to as an “Event”), then in addition to any
other rights the holders of the Convertible Debentures may have hereunder or under applicable law, the Company shall be in breach of
the term and conditions of this Agreement and such Event shall be deemed an event of default under the Convertible Debentures for so
long as such Event remains uncured.

 

    5

    

    

 

(f) Piggy-Back
Registrations. If at any time there is not an effective Registration Statement covering all of the Registrable Securities, or after
the Market Price Set Date there is not an effective Registration Statement covering all of the Warrant Shares, and the Company proposes
to register the offer and sale of any shares of its Common Stock under the Securities Act (other than a registration (i) pursuant to
a Registration Statement on Form S-8 ((or other registration solely relating to an offering or sale to employees or directors of the
Company pursuant to any employee stock plan or other employee benefit arrangement), (ii) pursuant to a Registration Statement on Form
S-4 (or similar form that relates to a transaction subject to Rule 145 under the Securities Act or any successor rule thereto), or (iii)
in connection with any dividend or distribution reinvestment or similar plan), whether for its own account or for the account of one
or more stockholders of the Company and the form of Registration Statement to be used may be used for any registration of Registrable
Securities or Warrant Shares, the Company shall give prompt written notice (in any event no later than five days prior to the filing
of such Registration Statement) to the holders of Registrable Securities and Pre-Paid Warrants of its intention to effect such a registration
and, shall include in such registration all Registrable Securities or Warrant Shares with respect to which the Company has received written
requests for inclusion from the holders of Registrable Securities; provided, however, that, the Company shall not be required
to register any Registrable Securities or Warrant Shares pursuant to this Section 10(c) that have been sold or may permanently be sold
without any restrictions pursuant to Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such
effect (based upon such representations of the Company and the Investor as such counsel may reasonably request), addressed and reasonably
acceptable to the Company’s transfer agent.

 

(g) For
not more than fifteen (15) consecutive days or for a total of not more than thirty (30) days in any twelve (12) month
period, the Company may suspend the use of any Prospectus included in any Registration Statement contemplated by this Section in the
event that the Company determines in good faith that such suspension is necessary to (A) delay the disclosure of material nonpublic
information concerning the Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the best
interests of the Company or (B) amend or supplement the affected Registration Statement or the related Prospectus so that such Registration
Statement or Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein, in the case of the Prospectus in light of the circumstances under which they were
made, not misleading (an “Allowed Delay”); provided, that the Company shall promptly (a) notify each Investor
in writing of the commencement (and the termination) of an Allowed Delay, but shall not (without the prior written consent of an Investor)
disclose to such Investor any material nonpublic information giving rise to an Allowed Delay, (b) advise the Investors in writing
to cease all sales under such Registration Statement until the end of the Allowed Delay, and (c) use commercially reasonable efforts
to terminate an Allowed Delay as promptly as practicable.

 

    6

    

    

 

3. RELATED
OBLIGATIONS.

 

(a) The
Company shall, not less than three business days prior to the filing of each Registration Statement and not less than one Trading Day
prior to the filing of any related amendments and supplements to all Registration Statements (except for supplements and amendments to
update the Registration Statement solely for information reflected in the Company’s annual reports on Form 10-K, quarterly reports
on Form 10-Q or current reports on Form 8-K) furnish to each Investor copies of all such documents proposed to be filed, which documents
(other than those incorporated or deemed to be incorporated by reference) will be subject to the reasonable and prompt review of such
Investor. The Investor shall furnish comments on the Registration Statement to the Company within 24 hours of the receipt thereof from
the Company and amendments or supplements thereto within 12 hours of the receipt thereof from the Company. The Company shall not file
a Registration Statement or any such Prospectus or any amendments or supplements thereto to which the Investor shall reasonably object
in good faith; provided that, the Company is notified of such objection in writing no later than two business days after the Investor
have been so furnished copies of a Registration Statement, provided further that the Company shall not be in breach of this Agreement
or in default under the Convertible Debentures pursuant to Section 2(e) hereof or Section (3) of any Convertible Debenture if failure
to meet the deadlines specified in Section 2(e) are due to any such objection by the Investor.

 

(b) The
Company shall furnish to each Investor whose Registrable Securities are included in any Registration Statement, without charge, (i) at
least one copy of such Registration Statement as declared effective by the SEC and any amendment(s) thereto, including financial statements
and schedules, all documents incorporated therein by reference, all exhibits and each preliminary prospectus, (ii) 10 copies of the final
prospectus included in such Registration Statement and all amendments and supplements thereto (or such other number of copies as such
Investor may reasonably request) and (iii) such other documents, which are not publicly available through EDGAR, as such Investor may
reasonably request from time to time in order to facilitate the disposition of the Registrable Securities owned by such Investor.

 

(c) The
Company shall use commercially reasonable efforts to (i) register and qualify the Registrable Securities covered by a Registration Statement
under such other securities or “blue sky” laws of such jurisdictions in the United States as any Investor reasonably requests,
(ii) prepare and file in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations
and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions
as may be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv)
take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, that the Company shall not be required in connection therewith or as a condition thereto to (w) make any change to its articles
of incorporation or by-laws, (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for
this Section 3(c), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service of process
in any such jurisdiction. The Company shall promptly notify each Investor who holds Registrable Securities of the receipt by the Company
of any notification with respect to the suspension of the registration or qualification of any of the Registrable Securities for sale
under the securities or “blue sky” laws of any jurisdiction in the United States or its receipt of actual notice of the initiation
or threat of any proceeding for such purpose.

 

    7

    

    

 

(d) The
Company shall promptly notify the Investors, at any time prior to the end of the Registration Period, upon discovery that, or upon the
happening of any event as a result of which the Prospectus included in a Registration Statement, as then in effect, includes an untrue
statement of a material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain any material,
nonpublic information), and promptly prepare, file with the SEC and furnish to the Investor a supplement to or amendment of such Prospectus
as may be necessary so that such Prospectus shall not include an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing.
The Company shall also promptly notify each Investor in writing (i) when a Prospectus or any Prospectus supplement or post-effective
amendment has been filed, and when a Registration Statement or any post-effective amendment has become effective (notification of such
effectiveness shall be delivered to each Investor by facsimile on the same day of such effectiveness), (ii) of any request by the SEC
for amendments or supplements to a Registration Statement or related prospectus or related information, and (iii) of the Company’s
reasonable determination that a post-effective amendment to a Registration Statement would be appropriate.

 

(e) The
Company shall use commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of a
Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction within
the United States of America and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the
earliest possible moment and to notify each Investor who holds Registrable Securities being sold of the issuance of such order and the
resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.

 

(f) The
Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless (i)
disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the release of such information is ordered
pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such
information has been made generally available to the public other than by disclosure in violation of this Agreement or any other agreement.
The Company agrees that it shall, upon learning that disclosure of such information concerning an Investor is sought in or by a court
or governmental body of competent jurisdiction or through other means, give prompt written notice to such Investor and allow such Investor,
at the Investor’s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such
information.

 

(g) The
Company shall use commercially reasonable efforts to cause all the Registrable Securities to be listed on each securities exchange on
which the Common Stock is then listed. The Company shall pay all fees and expenses in connection with satisfying its obligation under
this Section 3(i).

 

(h) The
Company shall cooperate with the holders of the Registrable Securities to facilitate the timely preparation and delivery of certificates
representing the Registrable Securities to be sold pursuant to such Registration Statement or Rule 144 free of any restrictive legends
and representing such number of shares of Common Stock and registered in such names as the holders of the Registrable Securities may
reasonably request a reasonable period of time prior to sales of Registrable Securities pursuant to such Registration Statement or Rule;
provided, that the Company may satisfy its obligations hereunder without issuing physical stock certificates through the use of
The Depository Trust Company’s Direct Registration System.

 

    8

    

    

 

(i) The
Company shall use commercially reasonable efforts to cause the Registrable Securities to be registered with or approved by such other
governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable Securities.

 

(j) The
Company shall otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the SEC in connection
with any registration hereunder.

 

(k) Within
two business days after a Registration Statement which covers Registrable Securities is declared effective by the SEC, the Company shall
deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with copies
to the Investor whose Registrable Securities are included in such Registration Statement) confirmation that such Registration Statement
has been declared effective by the SEC.

 

(l) The
Company shall take all other reasonable actions necessary to expedite and facilitate disposition by each Investor of Registrable Securities
pursuant to a Registration Statement.

 

4. OBLIGATIONS
OF THE INVESTOR.

 

(a) The
Investor agrees that, upon receipt of any notice from the Company either (i) the commencement of an Allowed Delay pursuant to Section
2(g) or (ii) the happening of any event pursuant to Section 3(d) hereof, such Investor will immediately discontinue disposition of Registrable
Securities pursuant to any Registration Statement covering such Registrable Securities until the Investor’s receipt of the copies
of the supplemented or amended prospectus contemplated by Section 3(d) or receipt of notice that no supplement or amendment is required.
Notwithstanding anything to the contrary, subject to compliance with the securities laws, the Company shall cause its transfer agent
to deliver unlegended certificates for shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities
Purchase Agreement in connection with any sale of Registrable Securities with respect to which an Investor has entered into a contract
for sale prior to the Investor’s receipt of such notice from the Company and for which the Investor has not yet settled.

 

(b)
The Investor covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable
to it or an exemption therefrom in connection with sales of Registrable Securities pursuant to the Registration Statement.

 

5. EXPENSES
OF REGISTRATION.

 

All
expenses incurred by the Company in complying with its obligations pursuant to this Agreement and in connection with the registration
and disposition of Registrable Securities shall be paid by the Company, including, without limitation, all registration, listing and
qualifications fees, printers, fees and expenses of the Company’s counsel and accountants (except legal fees of Investor’s
counsel associated with the review of the Registration Statement).

 

    9

    

    

 

6. INDEMNIFICATION.

 

(a) In
consideration of the Investor’s execution and delivery of the Transaction Documents (as defined in the Securities Purchase Agreement)
and acquiring shares of Convertible Debentures under the Securities Purchase Agreement and the Common Shares issuable upon conversion
thereof, and in addition to all of the Company’s other obligations under this Agreement and the other Transaction Documents, the
Company shall defend, protect, indemnify and hold harmless the Investor and its investment manager, Yorkville Advisors Global, LP, and
each of their respective officers, directors, managers, members, partners, employees and agents (including, without limitation, those
retained in connection with the transactions contemplated by this Agreement) and each person who controls the Investor within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively, the “Investor Indemnitees”) from
and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and reasonable
and documented expenses in connection therewith (irrespective of whether any such Investor Indemnitee is a party to the action for which
indemnification hereunder is sought), and including reasonable attorneys’ fees and disbursements (the “Indemnified Liabilities”),
incurred by the Investor Indemnitees or any of them as a result of, or arising out of, or relating to (a) any untrue statement or alleged
untrue statement of a material fact contained in any Registration Statement for the registration of the Registrable Securities as originally
filed or in any amendment thereof, or in any related prospectus, or in any amendment thereof or supplement thereto, or arise out of or
are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the
statements therein not misleading; provided, however, that the Company will not be liable in any such case to the extent
that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or
omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company by or
on behalf of the Investor specifically for inclusion therein; (b) any material misrepresentation or breach of any material representation
or material warranty made by the Company in any Transaction Document or any other certificate, instrument or document contemplated hereby
or thereby; or (c) any material breach of any material covenant, material agreement or material obligation of the Company contained in
any Transaction Document or any other certificate, instrument or document contemplated hereby or thereby. To the extent that the foregoing
undertaking by the Company may be unenforceable under applicable law, the Company shall make the maximum contribution to the payment
and satisfaction of each of the Indemnified Liabilities, which is permissible under applicable law

 

    10

    

    

 

(b) In
consideration of the Company’s execution and delivery of the Transaction Documents, and in addition to all of the Investor’s
other obligations under this Agreement and the other Transaction Documents, the Investor shall defend, protect, indemnify and hold harmless
the Company and all of its officers, directors, shareholders, employees and agents (including, without limitation, those retained in
connection with the transactions contemplated by this Agreement) and each person who controls the Company within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act (collectively, the “Company Indemnitees”) from and against
any and all Indemnified Liabilities incurred by the Company Indemnitees or any of them as a result of, or arising out of, or relating
to (a) any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement for the registration
of the Registrable Securities as originally filed or in any amendment thereof, or in any related prospectus, or in any amendment thereof
or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading; provided, however, that the Investor will
only be liable for written information relating to the Investor furnished to the Company by or on behalf of the Investor specifically
for inclusion in the documents referred to in the foregoing indemnity, and will not be liable in any such case to the extent that any
such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission
or alleged omission made therein in reliance upon and in conformity with written information furnished to the Investor by or on behalf
of the Company specifically for inclusion therein; (b) any misrepresentation or breach of any representation or warranty made by the
Investor in any Transaction Document or any instrument or document contemplated hereby or thereby executed by the Investor; or (c) any
breach of any covenant, agreement or obligation of the Investor contained in any Transaction Document or any other certificate, instrument
or document contemplated hereby or thereby executed by the Investor. To the extent that the foregoing undertaking by the Investor may
be unenforceable under applicable laws, the Investor shall make the maximum contribution to the payment and satisfaction of each of the
Indemnified Liabilities, which is permissible under applicable laws.

 

(c) Promptly
after receipt by an Investor Indemnitee or Company Indemnitee of notice of the commencement of any action or proceeding (including any
governmental action or proceeding) involving an Indemnified Liability, such Investor Indemnitee or Company Indemnitee, as applicable,
shall, if a claim for an Indemnified Liability in respect thereof is to be made against any indemnifying party under this Section 6 deliver
to the indemnifying party a written notice of the commencement thereof; but the failure to so notify the indemnifying party will not
relieve it of liability under this Section 6, except to the extent the indemnifying party is prejudiced by such failure. The indemnifying
party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying
party similarly noticed, to assume control of the defense thereof with counsel mutually reasonably satisfactory to the indemnifying party
and the Investor Indemnitee or Company Indemnitee, as the case may be; provided, however, that an Investor Indemnitee or Company Indemnitee
shall have the right to retain its own counsel with the actual and reasonable third party fees and expenses of not more than one counsel
for such Investor Indemnitee or Company Indemnitee to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained
by the indemnifying party, the representation by such counsel of the Investor Indemnitee or Company Indemnitee and the indemnifying party
would be inappropriate due to actual or potential differing interests between such Investor Indemnitee or Company Indemnitee and any
other party represented by such counsel in such proceeding. The Investor Indemnitee or Company Indemnitee shall cooperate fully with
the indemnifying party in connection with any negotiation or defense of any such action or claim by the indemnifying party and shall
furnish to the indemnifying party all information reasonably available to the Investor Indemnitee or Company Indemnitee which relates
to such action or claim. The indemnifying party shall keep the Investor Indemnitee or Company Indemnitee reasonably apprised as to the
status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement of
any action, claim or proceeding effected without its prior written consent, provided, however, that the indemnifying party shall not
unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the Investor
Indemnitee or Company Indemnitee, consent to entry of any judgment or enter into any settlement or other compromise which does not include
as an unconditional term thereof the giving by the claimant or plaintiff to such Investor Indemnitee or Company Indemnitee of a release
from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder, the indemnifying party
shall be subrogated to all rights of the Investor Indemnitee or Company Indemnitee with respect to all third parties, firms or corporations
relating to the matter for which indemnification has been made. The indemnification required by this Section 6 shall be made by periodic
payments of the amount thereof during the course of the investigation or defense, as and when bills are received and payment therefor
is due.

 

    11

    

    

 

(d) The
remedies provided for in this Section 6 are not exclusive and shall not limit any right or remedy which may be available to any indemnified
person at law or equity. The obligations of the parties to indemnify or make contribution under this Section 6 shall survive expiration
or termination of this Agreement. Notwithstanding the foregoing, no party shall be entitled to recover from the other party for punitive,
indirect, incidental or consequential damages.

 

7. CONTRIBUTION.

 

To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law;
provided, however, that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent
misrepresentation; and (ii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds
received by such seller from the sale of such Registrable Securities.

 

8. REPORTS
UNDER THE EXCHANGE ACT.

 

With
a view to making available to the Investor the benefits of Rule 144 promulgated under the Securities Act or any similar rule or regulation
of the SEC that may at any time permit the Investor to sell securities of the Company to the public without registration, and as a material
inducement to the Investor’s purchase of the Convertible Debentures, the Company represents, warrants, and covenants to the following:

 

(a) The
Company is subject to the reporting requirements of section 13 or 15(d) of the Exchange Act and has filed all required reports under
Section 13 or 15(d) of the Exchange Act during the 12 months prior to the date hereof (or for such shorter period that the issuer was
required to file such reports), other than Form 8-K reports.

 

(b) During
the Registration Period, the Company shall file with the SEC in a timely manner all required reports under Section 13 or 15(d) of the
Exchange Act (it being understood that nothing herein shall limit the Company’s obligations under the Securities Purchase Agreement)
and such reports shall conform to the requirement of the Exchange Act and the SEC for filing thereunder.

 

(c) The
Company shall furnish to the Investor so long as such Investor owns Registrable Securities, promptly upon request, (i) a written statement
by the Company that it has complied with the reporting requirements of Rule 144, (ii) a copy of the most recent annual or quarterly report
of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested
to permit the Investor to sell such securities pursuant to Rule 144 without registration.

 

    12

    

    

 

9. AMENDMENT
OF REGISTRATION RIGHTS.

 

Provisions
of this Agreement may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively
or prospectively), only with the written consent of the Company and Investor who then hold at least two-thirds (2/3) of the Registrable
Securities. Any amendment or waiver effected in accordance with this Section 9 shall be binding upon each Investor and the Company.
No such amendment shall be effective to the extent that it applies to fewer than all of the holders of the Registrable Securities. No
consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of any of this
Agreement unless the same consideration also is offered to all of the parties to this Agreement.

 

10. MISCELLANEOUS.

 

(a) A
Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to own of record such Registrable Securities
or owns the right to receive the Registrable Securities. If the Company receives conflicting instructions, notices or elections from
two or more Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or
election received from the registered owner of such Registrable Securities.

 

(b) No
Piggyback on Registrations. Except as otherwise disclosed to Investor on or before the date hereof, the Company shall not file any
other registration statements on Form S-3, Form S-1, or otherwise until the initial Registration Statement required hereunder is declared
effective by the SEC, provided that this Section 10(b) shall not prohibit the Company from filing amendments to registration statements
already filed. The Company shall not include any other securities on a Registration Statement unless otherwise agreed by the Investor.

 

(c) Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing
and will be deemed to have been delivered pursuant to the notice provisions of the Securities Purchase Agreement or to such other address
and/or electronic mail address and/or to the attention of such other person as the recipient party has specified by written notice given
to each other party five days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of
such notice, consent, waiver or other communication, (B) electronically generated by the sender’s email service provider containing
the time, date, and recipient email or (C) provided by a courier or overnight courier service shall be rebuttable evidence of personal
service, receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with this section.

 

(d) Failure
of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy,
shall not operate as a waiver thereof.

 

    13

    

    

 

(e) All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws
of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New
York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York.
The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York,
Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or thereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue
of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under
this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall
be deemed or operate to preclude any Buyer from bringing suit or taking other legal action against the Company in any other jurisdiction
to collect on the Company’s obligations to such Buyer or to enforce a judgment or other court ruling in favor of such Buyer. EACH
PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT
OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY.

 

(f) Assignment.

 

(i) Subject
to Section 10(k), this Agreement and the rights, duties and obligations of the Investor hereunder may only be assigned upon the transfer
of a Convertible Debenture or the Conversion Shares issued pursuant to a Convertible Debenture pursuant to the terms and restrictions
on transfer set forth in the Securities Purchase Agreement and the applicable Convertible Debenture.

 

(ii) This
Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and
the permitted assigns of the parties.

 

(iii) No
assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company
unless and until the Company shall have received (A) written notice of such assignment as provided in Section 10(f) hereof and (B) the
written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this
Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other
than as provided in this Section 10(f) shall be null and void.

 

(g) The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

 

    14

    

    

 

(h) This
Agreement may be executed in identical counterparts, both which shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to the other party. Facsimile or other electronically scanned and delivered
signatures (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the
Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com), including by e-mail attachment, shall be deemed
to have been duly and validly delivered and be valid and effective for all purposes of this Agreement.

 

(i) Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(j) The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
strict construction will be applied against any party.

 

(k) This
Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person.

 

[remainder
of page intentionally left blank]

 

    15

    

    

 

IN
WITNESS WHEREOF, the Investor and the Company have caused their respective signature page to this Registration Rights Agreement to
be duly executed as of the date first above written.

 

	 	COMPANY:

    

	 	 
	 	RUBICON
    TECHNOLOGIES, INC.
	 	 	 
	 	By:	/s/
    Kevin Schubert
	 	Name: 	Kevin Schubert
	 	Title:	 President

 

[Signature Page to Registration Rights Agreement]

 

    16

    

    

 

	 	INVESTOR:

     

	 	YA
    II PN, LTD.
	 	 
	 	By:	Yorkville Advisors Global, LP
	 	Its:	Investment Manager
	 	 	 
	 	 	By:	Yorkville Advisors Global II, LLC
	 	 	Its:	General Partner
	 	

     

	 	 	By:	/s/
    Matt Beckman
	 	 	Name:	Matt Beckman
	 	 	Title:	Member

 

[Signature Page to Registration Rights Agreement]

 

    17Exhibit
10.7

 

PRE-FUNDED
COMMON STOCK PURCHASE WARRANT

 

RUBICON
TECHNOLOGIES, INC.

 

NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND
MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL IN A FORM REASONABLY SATISFACTORY
TO THE ISSUER THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144
UNDER SAID ACT.

 

THIS
PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) issued on November 30, 2022 (the “Issue Date”)
certifies that, for value received, YA II PN, Ltd. or its permitted assigns hereunder (the “Holder”) is entitled,
upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after Market Price
Set Date (as defined below) and until this Warrant is exercised in full (the “Termination Date”), to subscribe for
and purchase from Rubicon Technologies, Inc., a Delaware corporation (the “Company”), up to such number of shares
of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”) as is equal to the product
of (a) $20,000,000.00 divided by (b) the Market Price (as subject to adjustment hereunder, the “Warrant Shares”).
The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section
1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the “Purchase Agreement”), of even date herewith, among the Company and the purchasers
signatory thereto with respect to the issuance of securities. Additional capitalized terms shall have the meaning set forth below.

 

		a)	“3-Month
                                            Reset Price” means the average of the daily VWAPs of the Common Stock during the
                                            three consecutive Trading Days immediately following the 3-month anniversary of the Market
                                            Price Set Date.

 

		b)	“6-Month
                                            Reset Price” means the average of the daily VWAPs of the Common Stock during the
                                            three consecutive Trading Days immediately following the 6-month anniversary of the Market
                                            Price Set Date.

 

		c)	“Market
                                            Price” means 100% of the average of the daily VWAPs of the Common Stock during
                                            the three consecutive Trading Days immediately following the Market Price Set Date.

 

		d)	“Market
                                            Price Set Date” means the earlier of (i) nine months after the Issue Date, or (ii)
                                            the date upon which all of the Convertible Debentures to be issued pursuant to the Purchase
                                            Agreement have been fully repaid or fully converted into shares of Common Stock.

 

     

     

    

 

		e)	“Trading
                                            Market” means any of NYSE, the Nasdaq Global Market, the Nasdaq Global Select Market,
                                            NYSE American, the OTCQB, or the OTCQX, and any successor to any of the foregoing markets
                                            or exchanges.

 

		f)	“VWAP” means,
                                            for any date, the price determined by the first of the following clauses that means, for
                                            any security as of any date, the daily dollar volume-weighted average price for such security
                                            on the Primary Market as reported by Bloomberg through its “Historical Prices –
                                            Px Table with Average Daily Volume” functions. 

 

Section
2. Exercise.

 

a) Exercise
of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Market Price Set Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise substantially in the form annexed hereto as Exhibit
A (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and
the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within
three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant
resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Holder and any
assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase
of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be
less than the amount stated on the face hereof.

 

b) Exercise
Price. The exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise
Price”).

 

    2

     

    

 

c) Cashless
Exercise. This Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in
which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A),
where:

 

	 	(A)	=
    as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice
    of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP from the open
    of “regular trading hours” and up to the time of the Holder’s execution of the applicable Notice of Exercise if
    such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours
    thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section
    2(a) hereof, or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading
    Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular
    trading hours” on such Trading Day;
	 	(B)	= the Exercise Price of
    this Warrant, as adjusted hereunder; and
	 	(X)	=
    the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if
    such exercise were by means of a cash exercise rather than a cashless exercise.

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).

 

d) Mechanics
of Exercise.

 

i. Delivery
of Warrant Shares Upon Exercise. Company shall cause the Warrant Shares purchased hereunder to be recorded on the books and records
of the Company’s transfer agent (the “Transfer Agent”) as credited to the account of the Holder by the date
that is three Trading Days after the latest of (i) the delivery to the Company of the Notice of Exercise, (ii) surrender of
this Warrant (if required), and (iii) payment of the aggregate Exercise Price as set forth above, including by means of a cashless exercise
(such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed
for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the
case of a cashless exercise) is received by the Company and all Taxes to be paid by the Holder (if any), pursuant to the terms hereof
prior to the issuance of such Warrant Shares, having been paid by the Warrant Share Delivery Date. Upon delivery of the Notice of Exercise,
the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise
Price (other than in the case of a cashless exercise) is received by the Company and all Taxes to be paid by the Holder (if any), pursuant
to the terms hereof prior to the issuance of such Warrant Shares, having been paid by the Warrant Share Delivery Date. As used herein,
“Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. 

 

ii. Delivery
of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant. 

 

    3

     

    

 

iii. Rescission
Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise which right shall not impair the right
of the Holder to sue for reasonably foreseeable damages if the Holder does not elect to rescind.

 

iv. No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.

 

v. Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer
Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established
clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares. 

 

vi. Withholding.
Notwithstanding any other provision of this Warrant, the Company, Transfer Agent, and their respective representatives, as applicable,
shall be entitled to deduct and withhold from any amount payable pursuant to this Warrant any such Taxes as may be required to be deducted
and withheld from such amounts (and any other amounts treated as paid for applicable Tax Law) under the Internal Revenue Code of 1986,
as amended (“Code”) or any other applicable Tax Law (as determined in good faith by the party so deducting or withholding
in its sole discretion). To the extent that any amounts are so deducted and withheld, such deducted and withheld amounts shall be treated
for all purposes of this Warrant as having been paid to the Person in respect of which such deduction and withholding was made. For purposes
hereof, “Taxes” means any and all federal, state, local, foreign or other taxes imposed by any Governmental Entity, including
all income, gross receipts, license, payroll, recapture, net worth, employment, excise, severance, stamp, occupation, premium, windfall
profits, environmental, customs, duties, capital stock, ad valorem, value added, inventory, franchise, profits, withholding, social security
(or similar), unemployment, disability, real property, personal property, sales, use, transfer, registration, governmental charges, duties,
levies and other similar charges imposed by a Governmental Entity in the nature of a tax, alternative or add-on minimum, or estimated
taxes, and including any interest, penalty, or addition thereto.

 

    4

     

    

 

vii.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of
this Warrant, pursuant to the terms hereof. 

 

e) Holder’s
Exercise Limitations. The Holder shall not have the right to exercise any portion of this Warrant (or any Convertible Debenture issued
by the Company pursuant to the Purchase Agreement (the “Convertible Debentures”)) or receive shares of Common Stock
hereunder or under any such Convertible Debenture to the extent that after giving effect to such conversion or receipt of such shares
of Common Stock, the Holder, together with any affiliate thereof, would beneficially own (as determined in accordance with Section 13(d)
of the Exchange Act and the rules promulgated thereunder) in excess of 4.99% of the number of shares of Common Stock (the “Limitation
Amount”) outstanding immediately after giving effect to such conversion or receipt of shares as payment of interest. Since
the Holder will not be obligated to report to the Company the number of shares of Common Stock it may hold at the time of a conversion
hereunder, unless the exercise at issue plus any conversions of any Convertible Debenture held by the Holder or its affiliates would
result in the issuance of shares of Common Stock in excess of 4.99% of the then outstanding shares of Common Stock without regard to
any other shares which may be beneficially owned by the Holder or an affiliate thereof, the Holder shall have the authority and obligation
to determine whether the restriction contained in this Section will limit any particular conversion hereunder and to the extent that
the Holder determines that the limitation contained in this Section applies, the determination of which portion of the amount of this
Warrant that is exercisable shall be the responsibility and obligation of the Holder. If the Holder has delivered an Exercise Notice
for a portion of this Warrant that, without regard to any other shares that the Holder or its affiliates may beneficially own other than
any Conversion Notices under any Convertible Debenture held by the Holder or its affiliates, would result in the issuance in excess of
the permitted amount hereunder, the Company shall notify the Holder of this fact and shall honor the conversion for the maximum portion
of the Warrant permitted to be converted on such Exercise Date in accordance with this Section (2)(e), and any portion submitted for
exercise in excess of the permitted amount hereunder shall remain outstanding under this Warrant To the extent that Exercise Notices
under this Debenture and Conversion Notices under the Convertible Debentures held by the Holder or its affiliates limit the shares of
Common Stock that may be issued pursuant to this Section, the Holder may direct the Company which Exercise Notice or Conversion Notice
shall have precedence. The Limitation Amount may be waived by a Holder (but only as to itself and its affiliates and not to any other
Holder) upon not less than 65 days prior notice to the Company. Other Holders shall be unaffected by any such waiver.

 

(f) Principal
Market Limitation. Notwithstanding anything in this Warrant to the contrary, the Company shall not issue any shares of Common Stock
upon exercise of this Warrant or any other Transaction Documents, if the issuance of such Common Stock, together with any Common Stock
issued in connection with any other related transactions that may be considered part of the same series of transactions, would exceed
the aggregate number of shares of Voting Stock that the Company may issue in this transaction in compliance with the Company’s
obligations under the rules or regulations of the New York Stock Exchange (“NYSE”) (the number of shares of Voting
Stock which may be issued without violating such rules and regulations is 32,401,001 and shall be referred to as the “Exchange
Cap”), except that such limitation shall not apply in the event that the Company (A) obtains the approval of its stockholders
as required by the applicable rules of NYSE for issuances of shares of Common Stock in excess of such amount or (B) concludes, after
consultation with outside counsel to the Company that such approval is not required, which conclusion shall be reasonably satisfactory
to the Buyers. The Exchange Cap shall be appropriately adjusted for any stock dividend, stock split, reverse stock split or similar transaction.
Notwithstanding anything to the contrary, if at any time after the Market Price Set Date, the Company has issued in excess of 95% of
the Common Stock available under the Exchange Cap (an “Exchange Cap Trigger”), the Company shall, at the Holder’s
option, exercisable at any time concurrently with, or after, the occurrence of an Exchange Cap Trigger, purchase this Warrant in whole
from the Holder by paying to the Holder an amount of cash equal to the product of (a) $20,000,000, multiplied by (b) the quotient of
(y) the number of Warrant Shares underlying this Warrant as of the date such payment is made (after taking into account all exercises
of this Warrant) divided by (z) the original number of Warrant Shares underlying this Warrant plus any increase pursuant to Section 3
to the number of Warrant Shares underlying this Warrant, which amount shall be paid in cash in five equal monthly installments on the
last day of each calendar month (or if such payment date is not a Trading Day, the next successive Trading Day) following the occurrence
of the Exchange Cap Trigger, with the first monthly payment due and payable to the Holder within 20 Trading Days after the date the Company
receives notice from the Holder of its election for the Company to purchase the Warrant pursuant to this Section 2(f). “Voting
Stock” means the Common Stock and the Class V common stock, par value $0.0001, of the Company.

 

    5

     

    

 

(g) Warrant
Purchase. Notwithstanding anything to the contrary, if at any time after the Issue Date, (i) an “Event of Default” described
in Sections 3(a)(ii), (iii) and (iv) of the Convertible Debentures (whether or not the Convertible Debentures are then outstanding) shall
have occurred, (ii) the Company fails to cause the Transfer Agent to transmit to the Holder the applicable portion of the Warrant Shares
in accordance with, and as and when required by, the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant
Share Delivery Date, provided that such failure shall be cured by delivery of the applicable portion of the Warrant Shares to the Holder,
or (iii) the Company shall fail to observe or perform any material covenant, agreement or warranty contained in, or otherwise commit
a material breach or default of any provision of this Warrant or any material breach, default, or “Event of Default” of any
Transaction Documents (as defined in the Purchase Agreement), which is not cured or remedied within the time prescribed therein or if
no time is prescribed within ten Trading Days (without duplication), the Company shall, at the Holder’s option, exercisable at
any time concurrently with, or after, the occurrence of an event described in clause (i), (ii) or (iii) of this Section 2(g) purchase
this Warrant in whole from the Holder by paying to the Holder an amount of cash equal to the product of (a) $20,000,000, multiplied by
(b) the quotient of (y) the number of Warrant Shares called for by this Warrant as of the date such payment is made divided by (z) the
original number of Warrant Shares underlying this Warrant plus any increase pursuant to Section 3 to the number of Warrant Shares underlying
this Warrant, which amount shall be paid within 20 Trading Days of the date of notice from the Holder.

 

Section
3. Certain Adjustments.

 

a) Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.

 

    6

     

    

 

b) Adjustment
to Number of Warrant Shares. On the three-month anniversary of the Market Price Set Date, if the 3-Month Reset Price is lower than
the Market Price, then the number of Warrant Shares shall be increased by multiplying (i) the number of unpurchased Warrant Shares
that are subject to this Warrant as of such date by (ii) a ratio equal to the product of the Market Price divided by the 3-Month
Reset Price. On the six-month anniversary of the Market Price Set Date, if the 6-Month Reset Price is lower than the lower of the Market
Price and the 3-Month Reset Price, then the number of Warrant Shares shall be increased by multiplying (i) the number of unpurchased
Warrant Shares that are subject to this Warrant as of such date by (ii) a ratio equal to the product of the lower of (x) the
Market Price and (y) the 3-Month Reset Price divided by the 6-Month Reset Price.

 

c) Pro
Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant based on the then-current Exercise Price (without regard to any limitations on exercise hereof, including without
limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if
no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (provided, however, that to the extent that the Holder’s right to participate in any such
Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate
in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to
such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as
its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). 

 

d) Fundamental
Transaction.

 

If,
at any time while the Warrants are outstanding,

 

	 	(i)	the Company,
    directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another
    person;
	 	(ii)	the Company, directly or
    indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
    its assets in one or a series of related transactions;
	 	(iii)	any direct or indirect
    purchase offer, tender offer or exchange offer (whether by the Company or another person) is completed pursuant to which holders
    of shares of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been
    accepted by the holders of 50% or more of the total voting power of the Company’s shares of Common Stock; 

 

    7

     

    

 

	 	(iv)	the Company, directly or
    indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of shares of Common
    Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged for
    other securities, cash or property, or 
	 	(v)	the Company, directly or
    indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
    without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another person or group of persons
    whereby such other person or group acquires 50% or more of the total voting power of the Company’s shares of Common Stock (not
    including any Company shares held by the other person or other persons making or party to, or associated or affiliated with the other
    persons making or party to, such stock or share purchase agreement or other business combination)  (each a “Fundamental
    Transaction”),

 

then,
upon any subsequent exercise of a Warrant, the Holder shall have the right to receive and the Warrants, without any action required on
behalf of the Holder, shall automatically convert in the Fundamental Transaction into the right to receive, for each share of Common
Stock that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the number
of shares of capital stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, or depositary
shares representing those shares, and any additional consideration (the “Alternate Consideration”) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to
apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock
in such Fundamental Transaction and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.

 

Notwithstanding
anything to the contrary, the Company shall deliver written notice (email acceptable) to the Holder of a pending, contemplated or consummated
Fundamental Transaction (the “Company Fundamental Transaction Notice”), which notice shall contain a summary of the material
terms of such Fundamental Transaction. Within 10 calendar days after Holder’s receipt of the Company Fundamental Transaction Notice,
Holder shall have the option to require that the Company or any Successor Entity (as defined below) purchase this Warrant from the Holder
promptly following the consummation of the Fundamental Transaction by paying to the Holder an amount of cash equal to the product of
(a) $20,000,000, multiplied by (b) the quotient of (y) the number of Warrant Shares called for by this Warrant as of the date such payment
is made divided by (z) the original number of Warrant Shares underlying this Warrant plus any increase pursuant to Section 3 to the number
of Warrant Shares underlying this Warrant, which amount shall be paid within 20 Trading Days of the date of notice from the Holder. The
Holder shall be entitled to receive either the cash consideration under this paragraph or the Alternate Consideration under the immediately
preceding paragraph but shall not be entitled to receive both.

 

    8

     

    

 

e) Calculations. All
calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

f) Notice
to Holder.

 

i. Adjustment
to Exercise Price. Whenever the Exercise Price or the number of Warrant Shares are adjusted pursuant to any provision of this Section
3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment. 

 

ii. Notice
to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of
the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property,
or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company,
then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email
address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

    9

     

    

 

Section
4. Transfer of Warrant.

 

a) Transferability.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole, upon surrender of this Warrant at the
principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form
attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the
making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment,
and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly
be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant
to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company
within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.
The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued. Notwithstanding any other provision of this Warrant, any assignment or transfer of this Warrant to any party
that is not a United States person within the meaning of section 7701(a)(30) of the Code shall be void ab initio. 

 

b) New
Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c) Warrant
Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant
Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.

 

d)
Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144 under the Securities Act, the Company may require, as a condition of allowing such transfer,
that the Holder or transferee of this Warrant, as the case may be, provides to the Company a customary certificate, the form and substance
of which certificate shall be reasonably satisfactory to the Company, to the effect that the transfer of this Warrant does not require
registration under the Securities Act.

 

    10

     

    

 

Section 5.
Representations. By accepting this Warrant, and in connection with the offer and delivery of this Warrant and the acquisition
of shares of Common Stock upon the exercise of this Warrant, Holder makes the following representations:

 

a)
Purchase for Own Account. Holder is acquiring the Warrant and Warrant Shares for its own account for investment purposes and not
with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under
or exempt from the registration requirements of the Securities Act; provided, however, that by making the representations herein, Holder
does not agree, or make any representation or warranty, to hold the Warrant or any of the Warrant Shares for any minimum or other specific
term and reserves the right to dispose of the Warrant or any of the Warrant Shares at any time in accordance with, or pursuant to, a
registration statement covering such transaction or an available exemption under the Securities Act. Holder does not presently have any
agreement or understanding, directly or indirectly, with any Person to distribute any of the Warrant or any of the Warrant Shares.

 

b)
Restricted Securities. Holder understands that the Warrant and the Shares of Common Stock to be acquired upon the exercise of
the Warrant are being offered and sold to it in reliance upon specific exemptions from the registration requirements of the Securities
Act and state securities laws and that the Company is relying upon the truth and accuracy of, and Holder’s compliance with, the
representations, warranties, agreements, acknowledgments and understandings of Holder set forth herein in order to determine the availability
of such exemptions and the eligibility of Holder to acquire the Warrant and Shares of Common Stock. Holder understands that the Shares
of Common Stock, when issued, shall be “restricted securities” under the federal securities laws inasmuch as they are being
acquired from the Company in a transaction not involving a public offering and that under such laws the Shares may be resold without
registration under the Securities Act only in certain limited circumstances. Consequently, Holder may have to bear the risk of owning
the shares for an indefinite period of time. Holder is familiar with Rule 144 under the Securities Act as presently in effect.

 

c)
Holder Status. At the time Holder was offered this Warrant, it was, and as of the date of this Warrant is, an “accredited
investor” as defined in Regulation D, Rule 501(a), promulgated under the Securities Act.

 

d)
Knowledge and Experience of Holder. Holder has such knowledge, sophistication and experience in business and financial matters
so as to be capable of evaluating the merits and risks of the prospective investment in the Shares of Common Stock to be acquired upon
exercise of the Warrant, and has so evaluated the merits and risks of such investment. Holder has had the opportunity to review the Company’s
documents filed with the U.S. Securities and Exchange Commission and to ask questions of, and receive answers from, the officers of the
Company concerning the Company, including its financial condition, results of operation and prospects, and the terms and conditions of
the Shares issuable upon the exercise of the Warrant sufficient to enable it to evaluate its investment. Holder has received all of the
information it considers necessary or appropriate for deciding whether to acquire the Shares to be acquired upon any exercise of the
Warrant. Holder understands that its acquisition of any Shares issuable upon the exercise thereto involves a significant degree of risk.
Holder understands that the market price of the Common Stock has been volatile and that no representation is being made as to the future
value of the Common Stock. Holder is able to bear the economic risk of acquiring the Shares of Common Stock to be acquired upon exercise
of the Warrant, and is able to afford a complete loss of such acquisition. Holder has sought, or has had the opportunity to seek, such
tax advice as Holder has considered necessary regarding the U.S. federal income tax consequences of the exercise of the Warrant. Holder
acknowledges that the Holder shall be responsible for any of the Holder’s tax liabilities that may arise upon any exercise of the
Warrant, and that the Company has not provided any tax advice or any other representation or guarantee regarding the tax consequences
of the exercise of the Warrant.

 

    11

     

    

 

e)
Legend. Holder understands that, until such time as a registration statement has been declared effective or the Shares issuable upon
exercise of the Warrant may be sold pursuant to Rule 144 under the Securities Act without any restriction as to the number of securities
as of a particular date that can then be immediately sold, the certificates evidencing the Shares of Company Common Stock will bear with
one or all of the following restrictive legends:

 

(i)
THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS; and

 

(ii)
any legend required by the securities laws of any state.

 

f)
Affiliate Status. Holder is not an “affiliate” (as defined in Rule 144 under the Securities Act) of the Company and
has not been an “affiliate” (as defined in Rule 144 under the Securities Act) of the Company within the three months immediately
preceding the issuance of this Warrant.

 

Section
6. Miscellaneous.

 

a) No
Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.

 

b) Loss,
Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

c) Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.

 

d) Authorized
Shares. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who
are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.
The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant
will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be
duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect
of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

    12

     

    

 

Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.

 

e) Jurisdiction.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.

 

f) Restrictions.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g) Non-waiver
and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that the right
to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase Agreement,
if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the
Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited
to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due
pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder. 

 

h) Notices.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.

 

    13

     

    

 

i) Limitation
of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.

 

j) Remedies.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.

 

k) Successors
and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.

 

l) Amendment.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.

 

m) Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n) Headings.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.

 

(Signature
Page Follows)

 

    14

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.

 

	 	RUBICON TECHNOLOGIES,
    INC.
	 	 	 
	 	By:	/s/ Kevin Schubert
	 	Name: 	Kevin Schubert
	 	Title:	President

 

    15

     

    

 

EXHIBIT
A

NOTICE
OF EXERCISE

 

	TO:	RUBICON
TECHNOLOGIES, INC.

 

(1)
The undersigned hereby elects to purchase ___________________________ Warrant Shares of the Company pursuant to the terms of the attached
Warrant dated November ___, 2022.

 

(2)
Payment shall take the form of (check applicable box):

 

		[_]	in
                                            lawful money of the United States, payable to the Company; or

 

		[_]	the
                                            cancellation of such number of Warrant Shares as is necessary, in accordance with the formula
                                            set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number
                                            of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection
                                            2(c).

 

(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

The
Warrant Shares shall be delivered to the following DWAC Account Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

 

[SIGNATURE
OF HOLDER]

 

	Name of Investing Entity: ___________________________________
	 
	Signature of Authorized Signatory of Investing Entity:
    ___________________________________
	 
	Name of Authorized Signatory: ___________________________________
	 
	Title of Authorized Signatory: ___________________________________
	 
	Date: ___________________________________

 

     

     

    

 

EXHIBIT
B

ASSIGNMENT
FORM

 

(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)

 

FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

	Name: ___________________________________	 
	 	 
	 	 
	Address: _________________________________	 
	 	 
	 	 
	Phone Number: ___________________________________	 
	 	 
	Email Address: ___________________________________	 
	 	 
	Dated: __________________________________________	 
	 	 
	Holder’s Signature: ___________________________________	 
	 	 
	 	 
	Holder’s Address: _________________________________	 
	                                ___________________________________	 
	                               ___________________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]